Delivery Order SPE2DB20D6037-SPE2DB23FC9VK

Award Date 11/28/22
Potential Completion Date 11/29/22
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $1,068.30 firm fixed-price contract is for the delivery of MOVIPREP POWDER PACKETS, with a completion date of June 12, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $1,001.76 and has an ultimate completion date of May 10, 2024. The contract is for the delivery of MOVIPREP powder packets, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $1,068.96 contract is for the supply of MOVIPREP powder packets, a pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with the DLA, which allows the agency to place orders for a comprehensive range of pharmaceutical items to support the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,505.84 contract is to provide MOVIPREP powder packets, a medication used for bowel preparation procedures. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a...
This federal contract award is for the procurement of MOVIPREP POWDER PACKETS by the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on March 1, 2023, with a ceiling value of $1,712.00 and an ultimate completion date of March 2, 2023. The contract is a delivery order under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,952.99 contract is to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract is part of DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $17,614.47 contract is for the delivery of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities and VA medical centers nationwide. DMS...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,198.92 firm fixed-price contract is for the provision of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $10,239.16, is for the delivery of a variety of pharmaceutical products, including prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities. The contract is part of the DLA's Medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a ceiling value of $59,037.15 and a performance period ending on July 19, 2024. DMS Pharmaceutical Group is a pharmaceutical wholesaler that specializes in providing a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). This delivery order...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB23FC9VK
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,230.97, is for the supply of MOVIPREP powder packets to support the recurring medical supply needs of military health facilities.

DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items. This IDC, which runs through December 31, 2025, complements DMS's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare facilities. Through these contract vehicles, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents.

Generated 10/23/24, 9:43 AM